中国P站

Mucosal Immune Homeostasis, Inflammatory Disorders, Chronic Inflammation, Autoimmune Diseases, Immune Dysregulation, Microbiota, Cytokine Imbalance

Introduction

The mucosal immune system plays a crucial role in protecting the body against pathogens while maintaining tolerance to harmless antigens, such as food and commensal bacteria. The mucosal immune system is composed of specialized tissues, including the mucosal-associated lymphoid tissues (MALT), and is primarily located in the gastrointestinal, respiratory, and urogenital tracts. Immune cells within these tissues, such as T cells, B cells, and dendritic cells, work in concert to maintain mucosal integrity and homeostasis [1].

Mucosal immune homeostasis is essential for preventing excessive inflammation. When this balance is disrupted, however, it can lead to chronic inflammatory responses and the development of autoimmune diseases. This dysregulation can occur due to several factors, including immune cell dysfunction, cytokine imbalances, and alterations in the microbiota. For example, in inflammatory bowel disease (IBD), a dysregulated immune response within the gut leads to chronic inflammation and tissue damage. In asthma, inappropriate immune activation at mucosal surfaces in the respiratory tract results in airway inflammation and bronchoconstriction [2].

Additionally, environmental factors, such as infections, diet, and pollutants, can influence the mucosal immune system and contribute to its dysregulation. The gut microbiota, in particular, plays a pivotal role in modulating mucosal immunity and maintaining balance. Disruptions in the microbiome (dysbiosis) have been implicated in numerous autoimmune and inflammatory diseases [3]. Understanding the mechanisms of mucosal immune homeostasis and the factors that contribute to its dysregulation is essential for developing targeted therapies for autoimmune and inflammatory disorders.

Methods

A comprehensive literature review was performed to examine the pathways linking mucosal immune dysregulation to chronic inflammation and autoimmune disorders. Studies selected for inclusion focused on the molecular and cellular mechanisms of mucosal immune regulation, with particular attention to immune cell dysfunction, inflammatory cytokine production, and microbiota composition in various autoimmune and inflammatory diseases, including IBD, asthma, and rheumatoid arthritis. Clinical studies, animal models, and reviews published in the last two decades were prioritized [4].

The data were analyzed and categorized into several key themes, such as immune dysregulation, microbiome alterations, inflammatory mediators, and the impact of environmental factors on mucosal immunity. This approach provided a comprehensive overview of current research on mucosal immune homeostasis and its disruption in autoimmune diseases [5].

Results

The review highlighted several key factors contributing to mucosal immune dysregulation and chronic inflammation. In autoimmune diseases such as inflammatory bowel disease (IBD), an imbalance between pro-inflammatory and anti-inflammatory cytokines contributes to sustained inflammation and tissue damage. Specifically, elevated levels of TNF-α, IL-6, and IL-17 are found in the inflamed mucosa, while anti-inflammatory cytokines like IL-10 are often reduced.

Similarly, in asthma, an overactive Th2 immune response leads to increased production of cytokines such as IL-4, IL-5, and IL-13, which drive eosinophilic inflammation and airway hyperreactivity. Dysregulation of T-helper cell differentiation and polarization is also a hallmark of chronic inflammatory diseases at mucosal sites.

Microbiota alterations (dysbiosis) were found to play a critical role in mucosal immune regulation. In IBD and other autoimmune conditions, an imbalance in gut microbiota composition, characterized by a loss of beneficial bacteria and an overgrowth of pathogenic species, promotes inflammation and immune activation. Studies showed that restoring a balanced microbiota through probiotics, dietary interventions, or fecal microbiota transplantation can alleviate inflammation and improve disease outcomes. Environmental factors, such as diet, smoking, and infections, also influence mucosal immune responses. These factors can either exacerbate existing inflammation or contribute to the onset of autoimmune diseases by disrupting mucosal immune balance.

Discussion

The mucosal immune system plays a central role in maintaining the body’s immune tolerance and preventing autoimmune and inflammatory diseases. When immune homeostasis is disrupted, chronic inflammation ensues, which can lead to tissue damage and disease progression. In diseases like inflammatory bowel disease (IBD), asthma, and rheumatoid arthritis, dysregulation of immune responses at mucosal surfaces leads to an inappropriate immune response against self-antigens, resulting in persistent inflammation [6]. The cytokine imbalance, with an overproduction of pro-inflammatory cytokines such as TNF-α, IL-6, and IL-17, and a reduction in anti-inflammatory mediators such as IL-10, has been shown to be a key feature in these diseases. Furthermore, alterations in the microbiota, or dysbiosis, have been consistently linked to immune dysregulation and chronic inflammation. The gut microbiome, in particular, plays a critical role in regulating immune responses, and its disruption is associated with a variety of autoimmune and inflammatory conditions [7]. Environmental factors, including infections, diet, and pollutants, also interact with the mucosal immune system and contribute to its dysregulation. These factors can act as triggers for autoimmune disease onset or exacerbate ongoing inflammation, highlighting the complex interplay between genetic, environmental, and immune factors. Understanding the molecular pathways involved in mucosal immune regulation is critical for identifying therapeutic targets. Future research should focus on developing strategies that restore immune balance, such as microbiome-based therapies, immune modulators, and personalized treatment approaches [8].

Conclusion

Mucosal immune homeostasis is essential for maintaining tolerance and preventing excessive inflammation at mucosal surfaces. Dysregulation of mucosal immunity is a key factor in the development of chronic inflammatory and autoimmune diseases, such as IBD, asthma, and rheumatoid arthritis. Immune cell dysfunction, cytokine imbalances, microbiota alterations, and environmental factors all contribute to the disruption of mucosal immune balance and the onset of these diseases.

Targeted therapies that aim to restore mucosal immune homeostasis, such as microbiome modulation and immune modulators, show promise in treating autoimmune and inflammatory disorders. Further research is needed to better understand the molecular pathways involved in mucosal immunity and to develop new therapeutic strategies that can effectively restore immune balance and improve disease outcomes.

References

1. Nakamura M, Saito H, Kasanuki J, Tamura Y, Yoshida S, et al. (1992) . Gut 33: 933-937.

   , ,

2. Brynskov J, Nielsen OH, Ahnfeldt RI, Bendtzen K (1992) . Scand J Gastroenterol 27: 897-906.

   , ,

3. Lieberman BY, Fiocchi C, Youngman KR, Sapatnekar WK, Proffitt MR, et al. (1988) . Dig Dis Sci 33: 1297-1304.

   , ,

4. Vallegarcia SM, Camacho GF, Poyato GA, Iglesias EM, Vega JF, et al. (2004) . Inflamm Bowel Dis 10: 701-702.

   , ,

5. Madonia S, Orlando A, Scimeca D, Olivo M, Rossi F, et al. (2007) . Inflamm Bowel Dis 13: 508-509.

   , ,

6. Papadakis KA, Tung JK, Binder SW, Kam LY, Abreu MT, et al. (2001) . Am J Gastroenterol 96: 2137 -2142.

   , ,

7. Elson CO, Sartor RB, Tennyson GS, Riddell RH (1995) . Gastroenterology 109: 1344-1367.

   , ,

8. Mac RP, Stenson WF (1988) . Adv Immunol 42: 285-328.

   , ,